Current and potentially novel antithrombotic treatment in acute ischemic stroke

A Ceulemans, HMH Spronk, H Ten Cate… - Thrombosis …, 2024 - Elsevier
Acute ischemic stroke (AIS) is the most common type of stroke and requires immediate
reperfusion. Current acute reperfusion therapies comprise the administration of intravenous …

Practical guide on left atrial appendage closure for the non-implanting physician: an international consensus paper

T Potpara, M Grygier, KG Häusler, JE Nielsen-Kudsk… - Europace, 2024 - academic.oup.com
A significant proportion of patients who suffer from atrial fibrillation (AF) and are in need of
thromboembolic protection are not treated with oral anticoagulation or discontinue this …

[HTML][HTML] Management of oral anticoagulant therapy after intracranial hemorrhage in patients with atrial fibrillation

F Luca, F Colivicchi, F Oliva, M Abrignani… - Frontiers in …, 2023 - frontiersin.org
Intracranial hemorrhage (ICH) is considered a potentially severe complication of oral
anticoagulants (OACs) and antiplatelet therapy (APT). Patients with atrial fibrillation (AF) …

Anticoagulation therapy in non-valvular atrial fibrillation after intracerebral hemorrhage: A propensity score–matched study

X Wang, W Chen, J Guo, D Wen, C You, L Ma - Journal of Clinical …, 2024 - Elsevier
Background The effect of antithrombotic therapy on patients with atrial fibrillation who
sustained previous intracerebral hemorrhage (ICH) remains uncertain. Data regarding …

[HTML][HTML] Memantine as a neuroprotective agent in ischemic stroke: preclinical and clinical analysis

D Pichardo-Rojas, PS Pichardo-Rojas… - Frontiers in …, 2023 - frontiersin.org
The primary mechanism for neuron death after an ischemic stroke is excitotoxic injury.
Excessive depolarization leads to NMDA-mediated calcium entry to the neuron and …

[PDF][PDF] Management of oral anticoagulant therapy after intracranial hemorrhage in patients with atrial fibrillation

C de Asmundis, M Matta, F Lucà, F Lucà, F Colivicchi… - 2023 - core.ac.uk
Intracranial Hemorrhage (ICH) is a well-recognized complication of oral anticoagulants
(OACs) and antiplatelet therapy (APT)(1, 2). In patients with atrial fibrillation (AF) treated with …